Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Effects on Bone Turnover in T2DM
NCT00732121Phase 4Unknown
- Sponsor
- The University of Vermont
- Start
- Aug 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by The University of Vermont. Status: unknown.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00732121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00732121.